ACICIS Public Health Study Tour

Published: 

About the program

The Public Health Study Tour (PHST) is a two-week intensive study tour that offers students a chance to gain insight into the public health sector in Indonesia. This is a unique opportunity for Australian students to hear from leading health professionals, policy-makers and community health workers in Indonesia, and to discuss approaches to health issues with Indonesian counterparts. Students will also have the opportunity to visit various health care facilities, organisations and schools in Indonesia which provide students with the opportunity to see firsthand how the public health system works in Indonesia and to understand the complex challenges it faces.

No background in Indonesian language is required to participate in this tour. Students from the following disciplines are welcome to apply; Public Health, Epidemiology, Occupational Health and Safety, Environmental Health, Health Promotion, Community Health, and Health Sciences. More information on this study option is available here: https://www.acicis.edu.au/programs/tour/public-health-study-tour/ 

Highlights

  • Experience Indonesian day-to-day life by living in-country
  • Collaborate with Indonesian peers
  • Gain insight in to major public health challenges (including COVID-19)
  • Learn from leading health professionals 

Enrolment Type and Fees

Enrolment Type: DIRECT ENROLMENT (Cross- Institutional Study)

Fees: AUD $4,336

Funding: AUD $3,000 New Colombo Plan Mobility Grants are available to eligible students.

Application Process

If you wish to transfer credit for the program, you must first seek approval from your faculty for credit transfer through Cross-Institutional Enrolment

For more information see - Applying for credit and funding for your overseas short course.

Ready to apply?

Apply for this program at https://www.acicis.edu.au/programs/tour/public-health-study-tour/  by 12 March 2023. Further instructions will then be sent to you by email.


More information

For further details:

 

Back to top